Understanding Market Cycles: When Could Biotech UnBoom? - a podcast by OIS Podcast

David Nierengarten, Managing Director, Wedbush Securities, explains how public market cycles could hit biotech and ophthalmology companies.

Further episodes of OIS Podcast | Ophthalmology

Further podcasts by OIS Podcast

Website of OIS Podcast